Suppr超能文献

多参数流式细胞术免疫表型分析在细胞学标本中T/NK细胞肿瘤中的价值:一项针对中国患者的回顾性研究

Value of multi-parameter flow cytometry immunophenotyping in T/NK-cell neoplasms in cytology specimens: A retrospective study in Chinese patients.

作者信息

Zheng Yuwei, Wan Xiaochun, Gui Xian, Chen Ying, Gao Lili, Zhang Hao, Wang Yanli

机构信息

Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, PR China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, PR China; Institute of Pathology, Fudan University, Shanghai 200032, PR China.

Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, PR China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, PR China; Institute of Pathology, Fudan University, Shanghai 200032, PR China.

出版信息

Pathol Res Pract. 2020 Aug;216(8):152921. doi: 10.1016/j.prp.2020.152921. Epub 2020 Mar 9.

Abstract

BACKGROUND

Innate limitations of morphological diagnosis of T/NK-cell neoplasms mean that they can be misdiagnosed or missed, especially when mixed with a variety of benign and reactive conditions. The aim of this study was to investigate the application value of multiparameter flow cytometry immunophenotyping (MFCI) in screening and diagnosing T/NK-cell neoplasms with cytology specimens.

MATERIAL AND METHODS

The clinical and pathological characteristics of 1028 newly diagnosed cases from Fudan University Shanghai Cancer Center who provided a cytology specimen between June 2010 and January 2016 with correlated histology diagnosis and clinical confirmation were retrospectively reviewed. MFCI was used for screening, diagnosis and typing. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) in diagnosis of T/NK-cell neoplasms were calculated.

RESULTS

There were 606 males and 422 females in 1028cases, with a mean age of 47.5 years (range 9-86 years). Specimens used for cytologic diagnosis included 996 FNAs, 2 US-FNAs, 13 EUS-FNAs and 17 effusions. Screening for types of lymphoma of MFCI, 139 (13.52 %) cases were T/NK cell lymphoma, 3 (0.29 %) cases were B cell lymphoma T-NHL and B-NHL coexist. A total of 146 suspected T/NK-cell neoplasms were screened out (sensitivity = 94.64 %, specificity = 95.63 % PPV = 72.60 %, NPV = 99.32 %) by MFCI, with 112 (76.71 %) histologically confirmed cases and 6 (4.11 %) false-negative cases identified (3 cases diagnosed as B-cell neoplasms and 1 case as T-cell neoplasm with B-cell neoplasm, which also were confirmed by gene rearrangement. 2 cases were suspicious T-cell-immunophenotypic abnormalities). When used at the diagnostic level, a total of 88 T/NK-cell neoplasms were identified (sensitivity = 68.75 %, specificity = 98.80 %, PPV = 87.50 %, NPV = 96.28 %) with 11 false-positive cases recognized, 9 of which showed typical immunophenotypic T-cell neoplasms features, and 2 exhibited aberrant T immunophenotype.

CONCLUSIONS

MFCI has high sensitivity and specificity in the screening and diagnosis of T/NK-cell neoplasms and may be useful as an alternative diagnosis method in cytology specimens.

摘要

背景

T/NK细胞肿瘤形态学诊断的固有局限性意味着它们可能被误诊或漏诊,尤其是当与各种良性和反应性病变混合时。本研究的目的是探讨多参数流式细胞术免疫表型分析(MFCI)在细胞学标本筛查和诊断T/NK细胞肿瘤中的应用价值。

材料与方法

回顾性分析2010年6月至2016年1月在复旦大学附属肿瘤医院新诊断的1028例提供了细胞学标本且有相关组织学诊断和临床确诊的病例的临床和病理特征。MFCI用于筛查、诊断和分型。计算MFCI诊断T/NK细胞肿瘤的敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)。

结果

1028例患者中男性606例,女性422例,平均年龄47.5岁(范围9 - 86岁)。用于细胞学诊断的标本包括996例细针穿刺抽吸活检(FNA)、2例超声引导下FNA、13例超声内镜引导下FNA和17例积液。MFCI筛查淋巴瘤类型,139例(13.52%)为T/NK细胞淋巴瘤,3例(0.29%)为B细胞淋巴瘤,T非霍奇金淋巴瘤(T-NHL)和B非霍奇金淋巴瘤(B-NHL)共存。MFCI共筛查出146例疑似T/NK细胞肿瘤(敏感性=94.64%,特异性=95.63%,PPV=72.60%,NPV=99.32%),其中112例(76.71%)经组织学确诊,6例(4.11%)为假阴性病例(3例诊断为B细胞肿瘤,1例诊断为T细胞肿瘤伴B细胞肿瘤,基因重排也证实了这一点。2例为可疑T细胞免疫表型异常)。在诊断水平使用时,共识别出88例T/NK细胞肿瘤(敏感性=68.75%,特异性=98.80%,PPV=87.50%,NPV=96.28%),识别出11例假阳性病例,其中9例表现出典型的免疫表型T细胞肿瘤特征,2例表现出异常T免疫表型。

结论

MFCI在T/NK细胞肿瘤的筛查和诊断中具有高敏感性和特异性,可作为细胞学标本的一种替代诊断方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验